Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenovirus Death Protein (ADP)
- Target
- ADP
- Molecular classification
- Membrane glycoprotein, Viral protein
01
Overview
The Adenovirus Death Protein (ADP), also known as E3-11.6K, is a small membrane glycoprotein encoded by the E3 region of adenoviruses. ADP is expressed at high levels during the very late phase of lytic adenoviral infection and plays a critical role in mediating efficient cell lysis and release of progeny virus particles from infected cells. It is also utilized in oncolytic virotherapy to enhance tumor-killing activity.
- Other names
- E3-11.6K
02
Mechanism of action
ADP promotes cell lysis, leading to the release of viral particles. In oncolytic virotherapy, ADP overexpression enhances tumor cell death.
03
Biological functions
Cell lysisVirion releaseRegulation of cell death
04
Disease associations
InfectionCancer (in the context of oncolytic virotherapy)
Beyond the preview
Go deeper on Adenovirus Death Protein (ADP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adenovirus Death Protein (ADP).